amwalalghad :: Life Style

Your English Portal To Arab Economy

Telecom Egypt   11.48        GMC GROUP FOR INDUSTRIAL COMME   1.29        Ismailia Misr Poultry   2.45        El Arabia for Investment & Dev   0.34        Modern Company For Water Proof   1.03        Pioneers Holding   2.84        Ezz Steel   7.86        Egyptian Real Estate Group   6.85        Rakta Paper Manufacturing   4.39        Orascom Telecom Holding (OT)   3.92        Naeem Holding   0.19        Egyptian Iron & Steel   6.87        Universal For Paper and Packag   4.94        Northern Upper Egypt Developme   4.93        Canal Shipping Agencies   7.39        Misr Chemical Industries   5.65        United Arab Shipping   0.43        Egyptians Housing Development    1.94        Egyptian for Tourism Resorts   0.69        Modern Shorouk Printing & Pack   7        Upper Egypt Contracting   0.8        Egyptian Financial Group-Herme   7.42        Orascom Construction Industrie   240.82        Heliopolis Housing   21.65        Raya Holding For Technology An   4.57        United Housing & Development   8.93        International Agricultural Pro   2.1        Gulf Canadian Real Estate Inve   18.08        Alexandria Pharmaceuticals   45.71        Arab Cotton Ginning   2.46        National Real Estate Bank for    11.84        Egyptian Chemical Industries (   7.26        Six of October Development & I   15.03        National Development Bank   6.72        Oriental Weavers   20.66        Arab Gathering Investment   16.29        Egyptians Abroad for Investmen   2.75        Credit Agricole Egypt   9.04        Palm Hills Development Company   1.61        Remco for Touristic Villages C   2.13        Commercial International Bank    29.87        El Ezz Porcelain (Gemma)   1.9        Egyptian Starch & Glucose   5.4        Arab Real Estate Investment (A   0.41        South Valley Cement   3.12        Citadel Capital - Common Share   2.5        Union National Bank - Egypt "    3.25        Ceramic & Porcelain   2.88        Rowad Tourism (Al Rowad)   5.05        El Nasr Transformers (El Maco)   4.78        Egyptian Media Production City   2.31        GB AUTO   27        Egyptian Transport (EGYTRANS)   7.85        Sharkia National Food   3.78        El Kahera Housing   4.97        El Shams Housing & Urbanizatio   2.45        Egyptian Kuwaiti Holding   0.7        ARAB POLVARA SPINNING & WEAVIN   2.11        Cairo Poultry   8.32        Egyptian Financial & Industria   8        T M G Holding   4.03        Asek Company for Mining - Asco   10.66        Misr Hotels   27        Egyptian Electrical Cables   0.56        Medinet Nasr Housing   22.51        Mena Touristic & Real Estate I   1.21        ELSWEDY CABLES   18        Prime Holding   0.91        Al Arafa Investment And Consul   0.17        Alexandria Spinning & Weaving    0.74        Gharbia Islamic Housing Develo   8.41        General Company For Land Recla   16.6        Alexandria Cement   8.9        Arab Valves Company   0.94        Sidi Kerir Petrochemicals   12.4        TransOceans Tours   0.09        Egyptian for Developing Buildi   6.43        Egyptian Gulf Bank   1.24        Kafr El Zayat Pesticides   18.19        Faisal Islamic Bank of Egypt -   35.1        National company for maize pro   11.86        Delta Construction & Rebuildin   4.03        Zahraa Maadi Investment & Deve   48.25        Samad Misr -EGYFERT   3.52        Egypt for Poultry   1.41        Cairo Development and Investme   11.7        Cairo Pharmaceuticals   20.1        Maridive & oil services   0.9        Suez Canal Bank   3.75        Nile Pharmaceuticals   15.81        The Arab Dairy Products Co. AR   73.85        National Housing for Professio   14.39        El Ahli Investment and Develop   4.87        Egyptian Saudi Finance Bank   10.79        Ismailia National Food Industr   5.16        National Societe Generale Bank   25.52        Acrow Misr   19.16        Alexandria Mineral Oils Compan   63.63        Paper Middle East (Simo)   5.59        Egypt Aluminum   12.31        Giza General Contracting   13.12        Middle Egypt Flour Mills   5.82        Extracted Oils   0.6        Assiut Islamic Trading   4.56        Engineering Industries (ICON)   3.95        North Cairo Mills   15.3        Arab Pharmaceuticals   11.88        Grand Capital   5.38        El Ahram Co. For Printing And    10.68        Minapharm Pharmaceuticals   25.49        El Arabia Engineering Industri   13.52        El Nasr For Manufacturing Agri   9.71        Naeem portfolio and fund Manag   1.7        Faisal Islamic Bank of Egypt -   6.76        Natural Gas & Mining Project (   68.26        Housing & Development Bank   13.95        East Delta Flour Mills   31.5        Orascom Development Holding (A   3.22        Memphis Pharmaceuticals   11.12        Abou Kir Fertilizers   134.23        Delta Insurance   5        Cairo Investment & Real Estate   12.18        Cairo Oils & Soap   12.98        Egyptian Arabian (cmar) Securi   0.36        Egyptian Real Estate Group Bea   15.56        Alexandria Containers and good   85.51        Upper Egypt Flour Mills   45.78        Development & Engineering Cons   9.94        Sinai Cement   15.18        Medical Union Pharmaceuticals   28.01        Torah Cement   24.2        Alexandria New Medical Center   46.55        Export Development Bank of Egy   5.04        Egyptian Company for Mobile Se   92.02        Middle & West Delta Flour Mill   32.7        El Kahera El Watania Investmen   4.18        Mansourah Poultry   12.41        Delta Sugar   11.04        Misr Beni Suef Cement   41.21        Egyptian Satellites (NileSat)   6.14        Cairo Educational Services   17.75        Lecico Egypt   7.55        Sharm Dreams Co. for Tourism I   5.3        General Silos & Storage   10.77        Al Moasher for Programming and   0.66        UTOPIA   5.28        Arab Ceramics (Aracemco)   25.4        Barbary Investment Group ( BIG   0.98        


Leisure - Life Style

Amwal Al Ghad English - 2017-09-24 11:18:29
Scientists have recently engineered a new antibody that attacks 99 percent of HIV strains and can prevent infection in primates. It is built to attack three critical parts of the virus - making it harder for HIV to resist its effects. The work is a collaboration between the US National Institutes of Health and the pharmaceutical company Sanofi. The International Aids Society said it was an "exciting breakthrough". Human trials will start in 2018 to see if it can prevent or treat infection. Our bodies struggle to fight HIV because of the virus' incredible ability to mutate and change its appearance. These varieties of HIV - or strains - in a single patient are comparable to those of influenza during a worldwide flu season. So the immune system finds itself in a fight against an insurmountable number of strains of HIV. Super-antibodies But after years of infection, a small number of patients develop powerful weapons called "broadly neutralising antibodies" that attack something fundamental to HIV and can kill large swathes of HIV strains. Researchers have been trying to use broadly neutralising antibodies as a way to treat HIV, or prevent infection in the first place. The study, published in the journal Science, combines three such antibodies into an even more powerful "tri-specific antibody". Dr Gary Nabel, the chief scientific officer at Sanofi and one of the report authors, told the BBC News website: "They are more potent and have greater breadth than any single naturally occurring antibody that's been discovered." The best naturally occurring antibodies will target 90% of HIV strains. "We're getting 99% coverage, and getting coverage at very low concentrations of the antibody," said Dr Nabel. Experiments on 24 monkeys showed none of those given the tri-specific antibody developed an infection when they were later injected with the virus. Dr Nabel said: "It was quite an impressive degree of protection." The work included scientists at Harvard Medical School, The Scripps Research Institute, and the Massachusetts Institute of Technology. 'Exciting' Clinical trials to test the antibody in people will start next year. Prof Linda-Gail Bekker, the president of the International Aids Society, told the BBC: "This paper reports an exciting breakthrough. "These super-engineered antibodies seem to go beyond the natural and could have more applications than we have imagined to date. "It's early days yet, and as a scientist I look forward to seeing the first trials get off the ground in 2018. "As a doctor in Africa, I feel the urgency to confirm these findings in humans as soon as possible." Dr Anthony Fauci, the director of the US National Institute of Allergy and Infectious Diseases, said it was an intriguing approach. He added: "Combinations of antibodies that each bind to a distinct site on HIV may best overcome the defences of the virus in the effort to achieve effective antibody-based treatment and prevention." More»
Amwal Al Ghad English - 2017-09-24 11:08:08
The rapid spread of "super malaria" in South East Asia is an alarming global threat, scientists warned. This dangerous form of the malaria parasite cannot be killed with the main anti-malaria drugs. It emerged in Cambodia but has since spread through parts of Thailand, Laos and has arrived in southern Vietnam. The team at the Oxford Tropical Medicine Research Unit in Bangkok said there was a real danger of malaria becoming untreatable. Prof Arjen Dondorp, the head of the unit, told the BBC News website: "We think it is a serious threat. "It is alarming that this strain is spreading so quickly through the whole region and we fear it can spread further [and eventually] jump to Africa." Failing treatments In a letter, published in The Lancet Infectious Diseases, the researchers detail the "recent sinister development" that has seen resistance to the drug artemisinin emerge. About 212 million people are infected with malaria each year. It is caused by a parasite that is spread by blood-sucking mosquitoes and is a major killer of children. The first choice treatment for malaria is artemisinin in combination with piperaquine. But as artemisinin has become less effective, the parasite has now evolved to resist piperaquine too. There have now been "alarming rates of failure", the letter says. Prof Dondorp said the treatment was failing around a third of the time in Vietnam while in some regions of Cambodia the failure rate was closer to 60%. Resistance to the drugs would be catastrophic in Africa, where 92% of all malaria cases happen. 'Against the clock' There is a push to eliminate malaria in the Greater Mekong sub-region before it is too late. Prof Dondorp added: "It's a race against the clock - we have to eliminate it before malaria becomes untreatable again and we see a lot of deaths. "If I'm honest, I'm quite worried." Michael Chew, from the Wellcome Trust medical research charity, said: "The spread of this malaria 'superbug' strain, resistant to the most effective drug we have, is alarming and has major implications for public health globally. "Around 700,000 people a year die from drug-resistant infections, including malaria. "If nothing is done, this could increase to millions of people every year by 2050." More»
Amwal Al Ghad English - 2017-09-06 10:15:55
Switzerland, a country famed for its services to chocolate, has unveiled a new kind of the sweet stuff called "Ruby". The pink hued chocolate, launched Tuesday, is the fourth type ever to be created and comes 80 years after the launch of White chocolate. Barry Callebaut, the chocolatiers behind the creation, say the new product will satisfy a new need among Millennials – those born since the early 80s – "hedonistic indulgence." 'Ruby' chocolate is characterised by a "fresh berry-fruitiness" and a distinct colour, which distinguishes it from its predecessors, Dark, Milk and White. It is made from the Ruby cocoa bean, which has a distinct set of attributes to those used in other chocolates, and is the result of several years of testing by Barry Callebaut. The product does not contain any berry flavoring or coloring, but the launch comes at a time when confectioners are under increasing pressure as consumers demonstrate a shift towards healthier alternatives. Global chocolate market volumes declined 1.5 percent in 2015 and 0.4 percent last year, according to Euromonitor. Switzerland, a country famed for its services to chocolate, has unveiled a new iteration of the sweet stuff called "Ruby". The pink hued chocolate, launched Tuesday, is the fourth type ever to be created and comes 80 years after the launch of White chocolate. Barry Callebaut, the chocolatiers behind the creation, say the new product will satisfy a new need among Millennials – those born since the early 80s – "hedonistic indulgence." 'Ruby' chocolate is characterised by a "fresh berry-fruitiness" and a distinct colour, which distinguishes it from its predecessors, Dark, Milk and White. It is made from the Ruby cocoa bean, which has a distinct set of attributes to those used in other chocolates, and is the result of several years of testing by Barry Callebaut. The product does not contain any berry flavoring or coloring, but the launch comes at a time when confectioners are under increasing pressure as consumers demonstrate a shift towards healthier alternatives. Global chocolate market volumes declined 1.5 percent in 2015 and 0.4 percent last year, according to Euromonitor. More»
Amwal Al Ghad English - 2016-12-25 09:30:24
Eating processed meat might make asthma symptoms worse, say researchers. Consuming more than four portions a week is a risk, suggests the study of nearly 1,000 French people, published in the journal Thorax. The researchers believe it could be a preservative called nitrite used in meats such as sausages, salami and ham that aggravates the airways. But experts say the link has not been proved and more investigations are needed. Rather than worry about one type of food, people should be eating a healthy and varied diet, they advise. More»
Amwal Al Ghad English - 2016-11-12 14:54:07
Very stressful events affect the brains of girls and boys in different ways, a Stanford University study suggests. A part of the brain linked to emotions and empathy, called the insula, was found to be particularly small in girls who had suffered trauma. But in traumatised boys, the insula was larger than usual. This could explain why girls are more likely than boys to develop post-traumatic stress disorder (PTSD), the researchers said. Their findings suggest that boys and girls could display contrasting symptoms after a particularly distressing or frightening event, and should be treated differently as a result. More»
Amwal Al Ghad English - 2016-10-09 08:59:40
An immunotherapy drug has been described as a potential "game-changer" in promising results presented at the European Cancer Congress. In a study of head and neck cancer, more patients taking nivolumab survived for longer compared with those who were treated with chemotherapy. In another study, combining nivolumab with another drug shrank tumours in advanced kidney cancer patients. Immunotherapy works by harnessing the immune system to destroy cancer cells. Advanced head and neck cancer has very poor survival rates. More»
Amwal Al Ghad English - 2016-09-24 14:37:42
A Shanghai restaurant has closed down a day after being awarded a Michelin star, reportedly because it lacked the necessary licences to operate. The Taian Table, which opened in April and served Western dishes, was described by Michelin as "graceful" and praised for its "clever recipes". But neighbours living above had complained of kitchen smoke and noise. The restaurant - one of 26 in the city to gain a star in the guide's first China edition - said it would relocate. More»
Amwal Al Ghad English - 2016-09-07 09:37:11
Rihanna says her new collection for Puma was inspired by Japanese street culture. The pop star launched the autumn/winter 2016 Fenty Puma by Rihanna line on Tuesday at Foot Locker in New York City. She says she remembers exploring fashion during her first trip to Japan years ago and leaving in awe. Her edgy collection, mostly in black and white, includes loose sweaters and pants, dresses, skirts, sneakers and sneaker heels. Fans screamed as Rihanna entered the venue, singing her songs that played in the background. She says she designed the line for her feverish fans. More»
Amwal Al Ghad English - 2016-09-04 08:01:11
Louis Vuitton has launched its first perfume range since the founding merger of its parent LVMH in 1987, targeting middle-income shoppers amid a downturn in luxury spending. This week's launch is an important step for the French brand as it tries to strike the delicate balance between increasing its number of more affordable goods while retaining its cachet. Until now, shoppers on more modest incomes have only been catered for by Louis Vuitton's key chains and very small leather goods, costing around 200-300 euros apiece. But the brand needs to boost sales growth after a sharp slowdown in the past three years, and with little sign of an industry recovery as security fears and geo-political uncertainty hit the tourism flows vital for luxury brands. More»
Amwal Al Ghad English - 2016-09-03 16:38:58
The U.S. Food and Drug Administration has issued on Friday a final rule that throws water on claims that antibacterial soaps and washes are more effective than regular soap. FDA issued a final rule establishing that over-the-counter (OTC) consumer antiseptic wash products containing certain active ingredients can no longer be marketed. Companies will no longer be able to market antibacterial washes with these ingredients because manufacturers did not demonstrate that the ingredients are both safe for long-term daily use and more effective than plain soap and water in preventing illness and the spread of certain infections. Some manufacturers have already started removing these ingredients from their products. This final rule applies to consumer antiseptic wash products containing one or more of 19 specific active ingredients, including the most commonly used ingredients – triclosan and triclocarban. These products are intended for use with water, and are rinsed off after use.  This rule does not affect consumer hand “sanitizers” or wipes, or antibacterial products used in health care settings. “Consumers may think antibacterial washes are more effective at preventing the spread of germs, but we have no scientific evidence that they are any better than plain soap and water,” said Janet Woodcock, M.D., director of the FDA’s Centre for Drug Evaluation and Research (CDER). “In fact, some data suggests that antibacterial ingredients may do more harm than good over the long-term.” The agency issued a proposed rule in 2013 after some data suggested that long-term exposure to certain active ingredients used in antibacterial products — for example, triclosan (liquid soaps) and triclocarban (bar soaps) — could pose health risks, such as bacterial resistance or hormonal effects. Under the proposed rule, manufacturers were required to provide the agency with additional data on the safety and effectiveness of certain ingredients used in over-the-counter consumer antibacterial washes if they wanted to continue marketing antibacterial products containing those ingredients. This included data from clinical studies demonstrating that these products were superior to non-antibacterial washes in preventing human illness or reducing infection. Antibacterial hand and body wash manufacturers did not provide the necessary data to establish safety and effectiveness for the 19 active ingredients addressed in this final rulemaking. For these ingredients, either no additional data were submitted or the data and information that were submitted were not sufficient for the agency to find that these ingredients are Generally Recognized as Safe and Effective (GRAS/GRAE). In response to comments submitted by industry, the FDA has deferred rulemaking for one year on three additional ingredients used in consumer wash products – benzalkonium chloride, benzethonium chloride and chloroxylenol (PCMX) – to allow for the development and submission of new safety and effectiveness data for these ingredients. Consumer antibacterial washes containing these specific ingredients may be marketed during this time while data are being collected. Washing with plain soap and running water remains one of the most important steps consumers can take to avoid getting sick and to prevent spreading germs to others. If soap and water are not available and a consumer uses hand sanitizer instead, the U.S. Centre for Disease Control and Prevention (CDC) recommends that it be an alcohol-based hand sanitizer that contains at least 60 percent alcohol. Since the FDA’s proposed rulemaking in 2013, manufacturers already started phasing out the use of certain active ingredients in antibacterial washes, including triclosan and triclocarban. Manufacturers will have one year to comply with the rulemaking by removing products from the market or reformulating (removing antibacterial active ingredients) these products. The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by helping to ensure the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for helping to ensure the safety and security of our nation’s food supply, cosmetics, dietary supplements, and products that give off electronic radiation, and for regulating tobacco products. More»